Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Metabolic Syndrome × Pioglitazone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3 Insulin Resistance 3 Sleep Apnea, Obstructive 1 Metabolic Syndrome 1 Glucose Intolerance 1 Diabetes Mellitus, Type 2 1 Carotid Intimal Medial Thickness 1 1

Interventions

Triptorelin Pamoate 1 Pioglitazone 1 Orchiectomy 1 Metformin 1 Leuprolide 1 Estrogens 1 Continuous Positive Airway Pressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated

37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡